Does BIMEKIZUMAB Cause Conjunctivitis? 14 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Conjunctivitis have been filed in association with BIMEKIZUMAB (Bimzelx). This represents 0.6% of all adverse event reports for BIMEKIZUMAB.
14
Reports of Conjunctivitis with BIMEKIZUMAB
0.6%
of all BIMEKIZUMAB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Conjunctivitis From BIMEKIZUMAB?
Of the 14 reports, and 1 (7.1%) were considered life-threatening.
Is Conjunctivitis Listed in the Official Label?
Yes, Conjunctivitis is listed as a known adverse reaction in the official FDA drug label for BIMEKIZUMAB.
What Other Side Effects Does BIMEKIZUMAB Cause?
Psoriatic arthropathy (615)
Psoriasis (400)
Drug ineffective (293)
Inappropriate schedule of product administration (238)
Injection site pain (225)
Product dose omission issue (163)
Off label use (160)
Oral candidiasis (146)
Fatigue (138)
Therapy interrupted (138)
What Other Drugs Cause Conjunctivitis?
DUPILUMAB (5,270)
ADALIMUMAB (457)
METHOTREXATE (385)
ETANERCEPT (306)
PREDNISONE (250)
SECUKINUMAB (237)
RITUXIMAB (222)
SULFAMETHOXAZOLE\TRIMETHOPRIM (218)
INFLIXIMAB (212)
LAMOTRIGINE (199)
Which BIMEKIZUMAB Alternatives Have Lower Conjunctivitis Risk?
BIMEKIZUMAB vs BIMEKIZUMAB-BKZX
BIMEKIZUMAB vs BINIMETINIB
BIMEKIZUMAB vs BIOFLAVONOIDS
BIMEKIZUMAB vs BIOTIN
BIMEKIZUMAB vs BIPERIDEN